Osivax
PrivateLast Round
Grant
Aug 26, 2025
Total Funding Raised
$70.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Osivax operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Grant round in August 2025.
Osivax is a biotechnology company that develops a transformative pipeline of universal vaccines designed to provide protection against viruses that mutate rapidly.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Osivax Comparables
Compare Osivax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Centivax, Inc. | 87% | |
| hVIVO plc | 83% | |
| FluGen, Inc. | 81% |
For institutional investors. Book with your work email.
Osivax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 26, 2025 | ||||
| Series B | Mar 4, 2025 | ||||
| Grant | Dec 5, 2023 | ||||
| Grant | Jun 23, 2022 | ||||
| Grant | Jul 8, 2020 | ||||
VC Round | Jul 8, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Osivax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Noshaq | Series A |
| Anaxago | Series A |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| European Innovation Council Fund | Grant, VC Round |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 281% MoM.
- Aug 26, 2025
$19.5M grant from Public Health Emergency Medical Countermeasures Enterprise.
For institutional investors. Book with your work email.
Osivax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Osivax's valuation, stock price, and market status.
Is Osivax a public or private company?
Osivax is a private company.
What is the current stock price of Osivax?
Osivax is a private company, so its shares have no public market price. Caplight tracks Osivax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Osivax worth (valuation)?
Valuation information for Osivax is not publicly available.
Can I buy Osivax stock?
Osivax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Osivax's last funding round?
Osivax's most recent funding round was Grant on August 26, 2025.
Who are the main investors in Osivax?
Key investors in Osivax include Noshaq.
Will Osivax IPO soon?
No public IPO plans have been announced for Osivax.
How can I track Osivax secondary market activity?
Caplight tracks bids, offers, and trades in Osivax's shares on secondary markets.